WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Chinese premier holds talks with Dominican PMChina Focus: 'Village Galas' Proving a Driving Force in Rural RevitalizationChildren Pick Strawberries at Hanging Strawberry Farm in E China's ZhejiangNew Attraction in Harbin: Ice Sculptures of Terracotta WarriorsMaglev Sightseeing Express Line Boosts Tourism in Fenghuang Ancient TownWorkers Produce Spring Festival Posters in China's ShandongChina's Nutrition Supply Continues to Improve in 2022: ReportChina's Xizang to Raise Educational Subsidy StandardZheng reaches Australian Open semifinals after fighting winChina to Further Enhance Medical Treatment for Critical Pregnant Women
3.3977s , 6604.4140625 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Global Grid news portal